Literature DB >> 11472160

Modeling the action of an antitumor drug: a density functional theory study of the mechanism of tirapazamine.

F Ban1, J W Gauld, R J Boyd.   

Abstract

Density functional theory methods are employed to investigate experimentally proposed mechanisms by which the antitumor drug tirapazamine may react with a DNA sugar-C(1)' radical to give the sugar derivative deoxyribonolactone, with concomitant DNA strand breakage. For the previously proposed minor pathway, ionization of the sugar-C(1)' radical by tirapazamine, the calculated ionization energy, and the electron affinity of the models of the sugar-C(1)' radical of DNA and tirapazamine suggest that tirapazamine must be protonated to be able to oxidize the sugar-C(1)' radical. The preferred mechanism for reaction of tirapazamine with a sugar-C(1)' radical, in agreement with experimental observations, is found to proceed by direct attack of an N-oxide oxygen of tirapazamine at the sugar-C(1)' position, followed by homolytic cleavage of the N-O bond of the drug moiety. Possible alternative mechanisms are also investigated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472160     DOI: 10.1021/ja010772a

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  3 in total

1.  A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates.

Authors:  Dmitri Zagorevskii; Minghu Song; Curt Breneman; Yang Yuan; Tarra Fuchs; Kent S Gates; C Michael Greenlief
Journal:  J Am Soc Mass Spectrom       Date:  2003-08       Impact factor: 3.109

2.  2'-deoxyribonolactone lesion produces G->A transitions in Escherichia coli.

Authors:  Virginie Faure; Jean-François Constant; Pascal Dumy; Murat Saparbaev
Journal:  Nucleic Acids Res       Date:  2004-05-24       Impact factor: 16.971

3.  Electronic structure and reactivity of tirapazamine as a radiosensitizer.

Authors:  José Romero; Thana Maihom; Paulo Limão-Vieira; Michael Probst
Journal:  J Mol Model       Date:  2021-05-22       Impact factor: 1.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.